Health Canada Approves Blenrep (belantamab mafodotin) Combinations for Relapsed or Refractory Multiple Myeloma (https://www.myeloma.org/news-events/multiple-myeloma-news/health-canada-approves-blenrep-belantamab-mafodotin-combo-rrmm)